System for in-vivo measurement of an analyte concentration

US8721544B2 · kind B2 · utility

Assignee

• Roche Diagnostics Operations, Inc. · US

Inventors

• Bernd Roesicke · Mannheim, DE
• Karin Obermaier · Zeven, DE
• Stefan Lindegger · Huttwil, CH
• Andreas Menke · Weingarten, DE
• Joerg Scherer · Aalen, DE
• Karin Schwind · Schifferstadt, DE
• Otto Gaa · Worms, DE
• Gregor Bainczyk · Mannheim, DE
• Michael Marquant · Mannheim, DE
• Sandro Niederhauser · Rütschelen, CH
• Michael Schoemaker · Mannheim, DE
• Martin Mueri · Basel, CH

Key dates

• Filing date: Mar 20, 2008
• Grant date: May 13, 2014
• Expiry date: Oct 16, 2032

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61B2560/0481
• WIPO field: Medical technology
• WIPO sector: Instruments

Abstract

The analyte concentration, such as glucose, in a human or animal body is measured with an implantable sensor that generates measurement signals. The measurement signals are compressed through statistical techniques to produced compressed measurement data that can is easier to process and communicate. A base station carries the implantable sensor along with a signal processor, memory, and a transmitter. A display device is also disclosed that can receive the compressed measurement data from the base station for further processing and display.